Delivery Order SPE2DB22D1103-SPE2DB25FTBU0

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat hyperphosphatemia in adults with chronic kidney disease on dialysis. The contract has a ceiling value of $5,659.64 and a period of performance through July 15, 2024. It is a firm fixed-price...
This is a $6,306.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat hyperphosphatemia in chronic kidney disease patients. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, for...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia in chronic kidney disease patients. The contract has a ceiling value of $1,888.29 and a performance period ending on July 24, 2024. AmerisourceBergen holds a...
This federal contract award, with ID SPE2DB20D1109|SPE2DB23FP98Y, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia associated with chronic kidney disease. The contract has a ceiling value of $26,558.84 and is structured as a delivery order with a firm fixed price. It does...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia. The contract has a firm fixed price of $6,272.28 and a completion date of November 12, 2024. The award is not designated as a set-aside contract, indicating open competition. This contract is likely part of a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,835.75 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets, a medication used in the treatment of hyperphosphatemia. The contract has an ultimate completion date of November 10, 2022 and was awarded on November 9, 2022. This delivery order is part of a larger $999,999,999...
This federal contract award, valued at $3,064.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Velphoro 500 mg chewable tablets, a medication used to treat high phosphorus levels in adults with chronic kidney disease on dialysis. The contract is a firm-fixed-price delivery order, with an ultimate completion date of June 13, 2024. It is not designated as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Velphoro 500 mg chewable tablets. The contract has a ceiling value of $6,784.58 and an ultimate completion date of December 8, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC, valued at up to...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $8,006.42 and runs through January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,185.54 firm fixed-price delivery order is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat high phosphorus levels in patients with chronic kidney disease on dialysis. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTBU0
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Velphoro 500 mg chewable tablets, a medication used to treat hyperphosphatemia associated with chronic kidney disease. The contract has a ceiling value of $3,805.71 and a completion date of November 18, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:21 PM